PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Attana AB

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Attana Announces New Reagents Launched in 2009 - Attana® AB today announced the launch of a series of four commercial reagents and kits to address the customers’ needs for ease of use and high quality research
Attana Announces New Reagents Launched in 2009

 

NewswireToday - /newswire/ - Stockholm, Sweden, 2009/02/11 - Attana® AB today announced the launch of a series of four commercial reagents and kits to address the customers’ needs for ease of use and high quality research.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In line with Attana vision and long term strategy for “ease of use” we are updating our product portfolio by introduction of a series of products for which quality and functionality are of importance; so as to increase reproducibility and high quality data.
“We are confident that this will improve the usability of our systems and strengthen our customers capabilities to get the best data quality for their research and development”, commented Johan Lindberg, Vice President Sales & Marketing.

The four commercial products launched are as follow, The Amine Coupling Kit (3501-3001) is used together with the Attana Carboxyl Sensor Chip for covalent immobilization of proteins or other molecules with primary amine groups. The special purity grade of EDC, together with sulfo-NHS, assures efficient immobilization of biomolecules, including proteins with low pI.

The Attana Streptavidin (3502-3001) enables immobilization of biotinylated molecules when used together with the Attana Biotin Sensor Chip. A high and consistent quality of the streptavidin is secured by repeated QC-testing together with associated Attana products.

The 10X HBS-T (3506-3001) running buffer is a sterile filtered high quality buffer suitable for convenient use with any Attana system.

The Attana Mouse-IgG Capture Kit (3518-3001) contains a specially selected polyclonal antibody that permits efficient and reproducible Fc-specific capture of mouse IgGs (e.g. from hybridomas) for applications such as off-rate screening and kinetic characterization.

All four products are available from Attana for immediate order and delivery. For purchase order, please contact Attana by orders[.]attana.com.

Alexander Kovacs, PhD., Global Product Manager, alexander.kovacs[.]attana.com.

Or visit the Attana website for ordering information and further product technical specifications.

About Attana
Based in Stockholm, Sweden, Attana (attana.com) is a pioneer in the development of continuous-flow Quartz Crystal Microbalance (QCM) systems for real time, label-free molecular interaction studies. Our systems have since 2003 been employed at leading universities and biotech companies in a wide variety of research fields within the life sciences.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Attana AB

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Attana Announces New Reagents Launched in 2009

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Li Huimin - Attana.com 
+46(0)8 410 200 00 huimin.li[.]attana.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Attana AB securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Attana AB / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)